A total approach to MDS and unanswered questions in the field

Approach to MDS in a Patient with AnemiaПодробнее

Unmet needs and unanswered questions in multiple myelomaПодробнее

The Biggest Unanswered Questions in Myeloma With Dr. Rajkumar, MDПодробнее

MDS: Factors to Consider in the Initial Treatment ApproachПодробнее

Myelodysplastic Syndrome (MDS)Подробнее

Myelodysplastic Syndromes | Exploring Current Considerations and Promising Investigational Approa...Подробнее

LG PathLab webinars - Myelodysplastic syndrome : An approach including case based discussionsПодробнее

Phil Chamberlain - Dana-Farber Targeted Degradation Webinar SeriesПодробнее

The Myelodysplastic Syndrome - Past is Prologue: Insight to Personalized TherapyПодробнее

BTK Inhibitors | Inside the Issue — Optimizing the Management of Adverse Events Associated with B...Подробнее

Myelodysplastic Syndrome (MDS) - a precursor to Acute Myeloid Leukemia (AML) ?! - Hematology SeriesПодробнее

WG Seminars: Cho, Immunological Modeling: Bridging Gaps in Clinical Data, August 25, 2022Подробнее

Genetic Predisposition to MDS - J ChurpekПодробнее

MedAI #69: Diagnosing failures of fairness transfer across distribution shift | Sanmi KoyejoПодробнее

Exploring Current Considerations and Promising Investigational Approaches for Patients with Myelo...Подробнее

The importance of CD47 as a target in MDS and AMLПодробнее

Myelodysplastic Syndrome- Not Just PreleukemiaПодробнее

Acute Myeloid Leukemia: Incorporating Novel Treatment Approaches into Clinical PathwaysПодробнее

Panel DiscussionПодробнее